Abstract
Introduction
Despite their prevalence and their profound impact on patient’s lives, chronic gynaecological disorders (such as endometriosis and adenomyosis) remain under-researched. Both to advance our understanding of the cellular behaviours underlying these conditions and to provide new tools for screening of potential therapies, advanced in vitro models are required. 3D patient-derived cultures that mimic the uterine wall, comprising both endometrial and myometrial cell types, are an attractive and unexplored route. Here, we describe an organon-a-chip approach to creating such cultures, demonstrating multiplexed, hormone-responsive uterine models within a microfluidic array.
Materials and Methods
Endometrial (obtained from pipelle biopsies) and myometrial (from patients undergoing elective C-sections) tissue samples were enzymatically dissociated to produce epithelial, stromal and myometrial cell fractions [1]. These cell suspensions were sequentially seeded into a microfluidic device with multiple, individually addressable channels, each containing a 5x5 microwell array. The devices were fabricated in PDMS and functionalised to create a non-adherent surface as previously published [2]. The resultant 3D cultures were maintained in vitro for up to 15 days and were subjected to hormone stimulation with β-estradiol (E2, 10 nM), medroxyprogesterone acetate (MPA, 100 nM) and cAMP (500 µM). Cellular organisation was monitored by live-cell imaging using fluorescent tracers and by end-point immunocytochemistry (pan-cytokeratin for epithelial cells, calponin for myocytes (SMCs), vimentin for stromal cells), with model functionality assessed by measuring IGFBP-1 and osteopontin secretion (by ELISA) following hormone stimulation.
Results and Discussion
A series of cell injection protocols, sequentially seeding the three cellular fractions over 2-4 days, were investigated. Regardless of protocol, epithelial cells ultimately localised to the outer periphery of the 3D cultures. Optimum results – where self-organisation resulted in robust 3D cultures with an outer epithelial layer encircling an inner myometrial core, thus mimicking the architecture of the uterine wall – were obtained when the myometrial cells were seeded last and when 5% (v/v) Matrigel® was incorporated into the culture media. Consistent cellular organisation was obtained when directly comparing patient-derived cultures produced from different endometrial biopsies (n=3, all biopsies from secretory phase tissue). Exposure of these cultures to E2, MPA and cAMP resulted in an increase in the secretion of both osteopontin and IGFBP-1, indicating stromal decidualisation [3].
Conclusions
These functional, 3D multicellular cultures show promise for personalised modelling of gynaecological disorders, enabling screening of patient-derived cultures in a medium-throughput format.
Despite their prevalence and their profound impact on patient’s lives, chronic gynaecological disorders (such as endometriosis and adenomyosis) remain under-researched. Both to advance our understanding of the cellular behaviours underlying these conditions and to provide new tools for screening of potential therapies, advanced in vitro models are required. 3D patient-derived cultures that mimic the uterine wall, comprising both endometrial and myometrial cell types, are an attractive and unexplored route. Here, we describe an organon-a-chip approach to creating such cultures, demonstrating multiplexed, hormone-responsive uterine models within a microfluidic array.
Materials and Methods
Endometrial (obtained from pipelle biopsies) and myometrial (from patients undergoing elective C-sections) tissue samples were enzymatically dissociated to produce epithelial, stromal and myometrial cell fractions [1]. These cell suspensions were sequentially seeded into a microfluidic device with multiple, individually addressable channels, each containing a 5x5 microwell array. The devices were fabricated in PDMS and functionalised to create a non-adherent surface as previously published [2]. The resultant 3D cultures were maintained in vitro for up to 15 days and were subjected to hormone stimulation with β-estradiol (E2, 10 nM), medroxyprogesterone acetate (MPA, 100 nM) and cAMP (500 µM). Cellular organisation was monitored by live-cell imaging using fluorescent tracers and by end-point immunocytochemistry (pan-cytokeratin for epithelial cells, calponin for myocytes (SMCs), vimentin for stromal cells), with model functionality assessed by measuring IGFBP-1 and osteopontin secretion (by ELISA) following hormone stimulation.
Results and Discussion
A series of cell injection protocols, sequentially seeding the three cellular fractions over 2-4 days, were investigated. Regardless of protocol, epithelial cells ultimately localised to the outer periphery of the 3D cultures. Optimum results – where self-organisation resulted in robust 3D cultures with an outer epithelial layer encircling an inner myometrial core, thus mimicking the architecture of the uterine wall – were obtained when the myometrial cells were seeded last and when 5% (v/v) Matrigel® was incorporated into the culture media. Consistent cellular organisation was obtained when directly comparing patient-derived cultures produced from different endometrial biopsies (n=3, all biopsies from secretory phase tissue). Exposure of these cultures to E2, MPA and cAMP resulted in an increase in the secretion of both osteopontin and IGFBP-1, indicating stromal decidualisation [3].
Conclusions
These functional, 3D multicellular cultures show promise for personalised modelling of gynaecological disorders, enabling screening of patient-derived cultures in a medium-throughput format.
Original language | English |
---|---|
Number of pages | 1 |
Publication status | Published - 19 Jun 2024 |
Event | Tissue and Cell Engineering Society Conference 2024 - Glasgow, United Kingdom Duration: 19 Jun 2024 → 21 Jun 2024 https://glasgow.thecemi.org/tces-joint-cdt-conference-2024/ |
Conference
Conference | Tissue and Cell Engineering Society Conference 2024 |
---|---|
Abbreviated title | TCES 2024 |
Country/Territory | United Kingdom |
City | Glasgow |
Period | 19/06/24 → 21/06/24 |
Internet address |
Keywords
- chronic gynaecological disorders
- uterine wall
- organ-on-a-chip
- microfluidic array